Baker Bros. Advisors LP Files Schedule 13G for KALA BIO, Inc.

Baker Bros. Advisors LP, along with Baker Bros. Advisors (GP) LLC, Julian C. Baker, and Felix J. Baker, have filed a Schedule 13G with the SEC regarding their holdings in KALA BIO, Inc. The filing indicates that the Reporting Persons collectively beneficially own 744,759 shares of Common Stock, representing 9.99% of the outstanding shares. The shares include 434,200 shares issuable upon the conversion of Series E Preferred Stock held directly by the Funds. The filing also details the ownership structure and the limitations on conversion of the Series E, F, G, and H Preferred Stock. The Reporting Persons have stated that they hold these securities in the ordinary course of business and not with the purpose of influencing the control of the issuer.